Ligand validation:3K54

1N1: N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE

1N1 is a Ligand Of Interest in 3K54 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3K54_1N1_A_1	45%	22%	0.183	0.913	0.92	2.29	2	15	0	0	100%	1
3OCT_1N1_A_663	79%	26%	0.103	0.949	0.9	2.05	1	13	1	0	100%	0.8788
8S9F_1N1_A_801	42%	13%	0.201	0.922	2.1	1.82	7	8	2	0	100%	1
5I9Y_1N1_A_1001	86%	24%	0.091	0.959	1.46	1.65	4	7	1	0	100%	0.45
5BVW_1N1_A_1009	83%	59%	0.1	0.957	0.54	1.02	-	4	0	0	100%	1
4QMS_1N1_A_401	80%	14%	0.101	0.949	1.7	2.17	5	13	0	0	100%	1
3G5D_1N1_A_1	79%	29%	0.102	0.947	1.22	1.63	3	6	0	0	100%	1
2Y6O_1N1_A_1892	79%	16%	0.108	0.952	2.1	1.57	10	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.